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Continuing Medical Education
New-Onset Seizures 15 Years After Renal Transplant
A 51-year-old female patient with a history of end-stage renal disease due to autosomal dominant polycystic kidney disease and resistant hyper-
tension underwent a deceased donor kidney transplant 15 years earlier. Her baseline blood urea nitrogen (BUN) level was 14 mg/dL, and her cre-
atinine level was 1.10 mg/dL. The patient experienced no complications except frequent urinary tract infections, which were easily treated. She
had no personal or family history of intracranial aneurysms. Her medication consisted of sirolimus, mycophenolate mofetil (MMF), clonidine,
atorvastatin, and calcium carbonate.
She was brought to the emergency room after a new-onset generalized tonic–clonic seizure. During the previous 2 months, she had been com-
plaining of constant fronto-occipital headaches and occasional diplopia, and was having regular appointments with her attending neurologist and
ophthalmologist. On arrival, her blood pressure was 159/80 mmHg. Her pulse was 78 beats per minute, and her temperature was 37°C. She had
no other relevant findings on physical examination. A thorough neurologic examination was conducted. She was still confused and slightly dys-
arthric, but she had no focal neurologic deficits and no meningeal signs. No abnormal findings were detected on fundoscopy. Initial blood tests
showed a raised white blood cell count (17 100/lL) with a low C-reactive protein and normal electrolytes. The serum creatinine level was
1.26 mg/dL, and BUN was 16.8 mg/dL. Her sirolimus trough level was 7.1 lg/L. A lumbar puncture was performed; cytochemical, bacterial, and
mycobacterial examinations were normal. Anti-neutrophil cytoplasmic antibodies and cryptococcal antigen detection in the cerebrospinal fluid
were negative. Polymerase chain reaction tests were negative for herpes family viruses, cytomegalovirus, Epstein–Barr virus, lymphocytic chori-
omeningitis virus, JC virus, enterovirus family, parvovirus B19, and Toxoplasma gondii. A plain cranial computed tomography (CT) scan was
ordered (Figure 1), followed by an MRI scan (Figure 2).
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Figure 1: Cranial CT showing bilateral frontal chronic
collections, with no apparent parenchymal findings.
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Questions
1. What is the most likely diagnosis?
a. Astrocytoma
b. Central nervous system vasculitis
c. Herpetic encephalitis
d. Posterior reversible encephalopathy syndrome
e. Ruptured intracranial aneurysm
2. What drugs have been implicated in this disease?
a. Calcineurin inhibitors and sirolimus
b. Clonidine
c. HMG-CoA inhibitors (statins)
d. Prednisone
e. Valganciclovir
3. What is the recommended course of action?
a. High-dose corticosteroids and cyclophosphamide
b. Control of blood pressure and change in immunosuppressive drugs
c. Immediate withdrawal of all immunosuppressive drugs
d. High-dose corticosteroids and localized radiotherapy
e. Urgent surgical trepanation
4. What is the expected outcome after adequate treatment?
a. 20% mortality rate
b. Complete remission of symptoms
c. Permanent cortical blindness
d. Progressive neurodegenerative disorder
e. Recurrent seizures
Figure 2: Cranial MRI showing a T2 hyperintense signal in the
cortico-subcortical region of the left parieto-occipital lobes.
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